Schonfeld Strategic Advisors LLC Abbott Laboratories Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 78,750 shares of ABT stock, worth $9.14 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
78,750
Previous 103,010
23.55%
Holding current value
$9.14 Million
Previous $11.7 Million
30.12%
% of portfolio
0.06%
Previous 0.08%
Shares
26 transactions
Others Institutions Holding ABT
# of Institutions
3,155Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.64 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.34 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.65 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $203B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...